The Market for Generic Drugs

Kalorama Information
July 1, 1998
217 Pages - SKU: AA541
Attention: There is an updated edition available for this report.
License type:
Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

The Market for Generic Drugs
  • CHAPTER ONE--Executive Summary (pp. 15-38) US $325.00
    • Market Size and Forecast
    • The Products
    • Product Descriptions
      • Prescription Generic Cardiovascular Drugs (pp. 22-25) US $70.00
      • Prescription Generic Anti-Infective Drugs (pp. 25-26) US $48.00
      • Prescription Generic Respiratory and Allergy Drugs (pp. 26-27) US $48.00
      • Prescription Generic Central Nervous System and Psychotherapeutic Drugs (pp. 27-29) US $48.00
      • Prescription Generic Analgesic, NSAIDs, and Antiarthritic Drugs
      • Prescription Generic Gastrointestinal Drugs
      • Gastrointestinal
      • Prescription Generic Hormone Drugs (pp. 31-33) US $48.00
      • Prescription Generic Cancer Drugs (pp. 33-35) US $48.00
      • Prescription Generic Ophthalmic Drugs
    • Trends Affecting the Market
    • Industry Structure and Leading Competitors
    • Scope and Methodology
  • CHAPTER TWO--The Product (pp. 39-100) US $594.00
    • Introduction
    • Market Segmentation
    • Prescription Generic Anti-Infective Drugs
    • Prescription Generic Respiratory and Allergy Drugs
    • Prescription Generic Central Nervous System and Psychotherapeutic Drugs
    • Prescription Generic Analgesic, NSAIDs, and Anti-arthritic Drugs
    • Prescription Generic Gastrointestinal Drugs
    • Prescription Generic Hormone Drugs
    • Prescription Generic Cancer Drugs
    • Prescription Generic Ophthalmic Drugs
  • CHAPTER THREE--Issues and Trends (pp. 101-134) US $353.00
    • Development Process of Prescription Generic Drugs for Consumers
    • Electronic Submissions
    • Merger and Acquisition Activity
    • Drug Treatment Trends
    • Legislation and Legal Issues
    • Organizational Issues
    • Bioequivalency Ratings
    • Generic Bulk Issues
    • Mail Order Generic Drugs
    • Biotech Activities
    • Advertising of Generic Drugs
    • Consumer Advertising
    • Controlling Costs
    • Consumer Issues and Trends
    • Consumer Savings
    • Distribution of Prescription Generic Drugs to Consumers
    • The Elderly
  • CHAPTER FOUR--The Market (pp. 135-179) US $376.00
    • Scope and Methodology
    • Market Size and Growth
  • CHAPTER FIVE--Competitor Profiles (pp. 179-219) US $470.00
    • Industry Structure and Participants
    • AKORN, INC.
    • ALPHARMA, INC.
    • APOTHECON
    • BARR LABORATORIES, INC.
    • COPLEY PHARMACEUTICAL, INC.
    • DEY LABORATORIES, INC.
    • ESI LEDERLE
    • GENEVA PHARMACEUTICALS, INC.
    • GENSIA SICOR, INC.
    • MYLAN LABORATORIES, INC.
    • ROXANE LABORATORIES, INC.
    • TEVA PHARMACEUTICALS, USA
    • WATSON PHARMACEUTICALS, INC.
    • ZENITH GOLDLINE LABORATORIES


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Generics Drugs Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!